公司资料
Opko 股价、新闻与催化剂
已退市
- 股票代码:
- OPKO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for OPKO.
公司概览
业务概览
Opko is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Opko is followed within the biotech universe for its exposure to catalyst-driven execution.
商业模式特征
Opko follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
生物医药行业定位
Compared with more mature healthcare peers, Opko sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
未来催化剂
- OPKO's near-term narrative is still split between diagnostics and the clinical pipeline, but the update feels more specific than usual. MDX2301 and the completed Epstein-Barr vaccine trial are the two pieces that can make the next stretch feel tangible, especially if they keep advancing without needing a reset in direction.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。